GL Pharm Tech Corp banner
G

GL Pharm Tech Corp
KOSDAQ:204840

Watchlist Manager
GL Pharm Tech Corp
KOSDAQ:204840
Watchlist
Price: 1 114 KRW 3.15% Market Closed
Market Cap: ₩86.4B

GL Pharm Tech Corp
EPS (Diluted)

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

GL Pharm Tech Corp
EPS (Diluted) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
G
GL Pharm Tech Corp
KOSDAQ:204840
EPS (Diluted)
₩3
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
1%
Yuhan Corp
KRX:000100
EPS (Diluted)
₩2.6k
CAGR 3-Years
27%
CAGR 5-Years
-3%
CAGR 10-Years
3%
SK Biopharmaceuticals Co Ltd
KRX:326030
EPS (Diluted)
₩3.4k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
EPS (Diluted)
₩13.4k
CAGR 3-Years
27%
CAGR 5-Years
68%
CAGR 10-Years
0%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
EPS (Diluted)
₩226
CAGR 3-Years
-5%
CAGR 5-Years
N/A
CAGR 10-Years
-9%
C
Caregen Co Ltd
KOSDAQ:214370
EPS (Diluted)
₩411
CAGR 3-Years
-10%
CAGR 5-Years
-33%
CAGR 10-Years
N/A
No Stocks Found

GL Pharm Tech Corp
Glance View

Market Cap
86.4B KRW
Industry
Pharmaceuticals

GL Pharm Tech Corp. engages in the provision of pharmaceutical research and development services and in the manufacture and sale of pharmaceutical products. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2014-11-20.

Intrinsic Value
632.97 KRW
Overvaluation 43%
Intrinsic Value
Price ₩1 114
G

See Also

What is GL Pharm Tech Corp's EPS (Diluted)?
EPS (Diluted)
3.9 KRW

Based on the financial report for Sep 30, 2025, GL Pharm Tech Corp's EPS (Diluted) amounts to 3.9 KRW.

What is GL Pharm Tech Corp's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
1%

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett